But there was no indication of protection against all-cause death, kidney disease progression or kidney failure, and there was increased risk of genital infection.
SGLT2 inhibitors may cut risk for heart failure hospitalization
Sep 28, 2021
SGLT2 inhibitors, compared with GLP-1 RAs, linked to lower risk for heart failure hospitalization in patients with T2DM, with or without cardiovasular disease.
Cardiovascular events up for individuals hospitalized with COVID-19
Oct 25, 2022
The largest effect sizes were seen for venous thromboembolism, heart failure and stroke; the risks were highest in the first 30 days.
Heart failure mortality lower with healthier food environment
Oct 25, 2022
A lower county food insecurity percentage and a higher county food environment index were linked to a lower heart failure mortality rate.
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
Dec 27, 2023
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.
Burden of heart disease considerable for American Indians, Alaska Natives
Sep 26, 2023
Half of the participants reported at least one severe cardiovascular condition; the overall mortality rate was 19.8%.
Hypertension while lying down tied to worse cardiovascular disease outcomes
Sep 13, 2023
Findings seen regardless of whether hypertension persists in seated position
Hello Heart, goodbye blood pressure? Mobile app monitoring has ‘overwhelming’ benefit for seniors:...
By
Aaron Dorman
Mar 25, 2024
A smartphone app, Hello Heart, has shown overwhelming promise in being able to reduce blood pressure among seniors, a new report showed.
Drug-delivery device for heart failure could get seniors to post-acute settings sooner
By
Aaron Dorman
Nov 29, 2023
A new drug infusion device could allow older adults who have heart failure to get treatment from a home or long-term care facility.
Living near fracking tied to increase in hospitalizations in seniors
Mar 22, 2023
Older adults who lived near fracking sites had excess hospitalizations for cardiovascular diseases.